Leukemia Posts Page 2 on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

CLL With a 17p Deletion: What Is the Treatment Plan?

Posted by on Jan 3, 2018 in Leukemia | 0 comments

Video information: Precision medicine allows for treatment plans to line up with a specific genetic profile. Find out from Dr. Michael Keating what is used to target CLL patients with a 17p deletion and when treatment should generally start. Dr. Keating also shares other genetic mutations to be aware of, and which tests are used to locate...

Read More

Detecting, Identifying and Treating Subtypes of CLL

Posted by on Jan 3, 2018 in Leukemia | 0 comments

Video information: Every patient’s CLL is different, so how do doctors tell which CLL treatment is best? Dr. Kathryn Kolibaba, with Compass Oncology, and Dr. Stephen Spurgeon, from OHSU Knight Cancer Institute, discuss modern tests used to distinguish subtypes of CLL and find a therapy to match. The experts also share their thoughts on the...

Read More

Understanding the Basics of CLL

Posted by on Jan 3, 2018 in Leukemia | 0 comments

Video Information: What is going on in the body of a person with chronic lymphocytic leukemia (CLL)? Increase your understanding of the condition as CLL experts Dr. Michael Keating and Dr. Kathryn Kolibaba break down the basics of the disease. Transcript: Andrew Schorr: So the idea is we have targeted therapy, and you knock back the cancer....

Read More

Decoding Monoclonal Antibodies

Posted by on Jan 3, 2018 in Leukemia | 0 comments

Video information: What are monoclonal antibodies targeting in the fight against CLL? Join us to hear from experts, Dr. Stephen Spurgeon and Dr. Jeff Sharman, as they dissect the scientific terminology that describes the monoclonal antibody family and their intended targets in the body. Transcript: Andrew Schorr: We have all these other drugs...

Read More

A new treatment combination for patients with relapsed Philadelphia chromosome positive leukemia

Posted by on Dec 30, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the combination of blinatumomab (Blincyto) and a tyrosine kinase inhibitor in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia. This study concluded that this combination was safe and effective for this group of patients.  Some background Philadelphia...

Read More

An analysis comparing reduced-intensity conditioning and myeloablative therapy for CLL

Posted by on Dec 30, 2017 in Leukemia | 0 comments

In a nutshell This study analyzed the results of 37 studies comparing myeloablative therapy and reduced intensity conditioning (RIC) before stem cell transplantation in patients with chronic lymphocytic leukemia (CLL). This study concluded that RIC was associated with lower mortality and better survival compared to myeloablative therapy. Some...

Read More

Updated recommendations for treating fungal infections in patients with hematological malignancies

Posted by on Dec 30, 2017 in Leukemia | 0 comments

In a nutshell This report aimed to update recommendations from 2014 about primary prevention of invasive fungal infections in patients with hematological malignancies (blood cancers). There were several updates to the recommendations.  Some background Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are hematological...

Read More

Peonies and Hope

Peonies and Hope

Posted by on Dec 23, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 2 comments

“People are like peonies, they need a good hard frost to bring out the character.” ~Francis “Doc” Winter “Doc” Winter was a Midwesterner.  Born in Iowa in 1931, in the midst of the Great Depression, he grew up on a small farm.  He knew about hard frosts. Struggle, pain and suffering are part of life.  Joy, love and...

Read More

Can donor age and kinship affect the outcome of stem cell transplants for acute leukemia patients?

Posted by on Dec 22, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if donor age and kinship affected the outcome of haploidentical hematopoietic cell transplantation for acute leukemia patients. This study concluded that both factors can affect the outcome for these patients.   Some background Haploidentical hematopoietic cell transplantation (halpo-HCT)...

Read More